Tobacco dependence treatment among service users prescribed clozapine and other psychotropic medication: Ensuring safe practice

As tobacco dependence treatment services continue to expand, it is critical that healthcare systems make smoking cessation both accessible and appealing to individuals with mental illness, to help them realize the significant health benefits of quitting. However, clinical safety considerations must be carefully managed when integrating these services, as smoking and stopping smoking can introduce risks due to drug interactions with psychotropic medications. This talk will emphasize the importance of a coordinated, system-wide approach to address these challenges, ensuring that clinical safety concerns are managed without hindering access to effective cessation support.